Patient-reported treatment satisfaction measures for long-term anticoagulant therapy

References

• Ansell J, Hirsh J, Poller L et al. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest126, 204S–233S (2004).
   PubMed Web of Science ®Google Scholar
• Buller HR, Agnelli G, Hull RD et al. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest126, 401S–428S (2004).
   PubMedGoogle Scholar
• Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am. J. Cardiol.82, 2N–9N (1998).
   PubMed Web of Science ®Google Scholar
• Singer DE, Albers GW, Dalen JE et al. Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest126, 429S–456S (2004).
   PubMedGoogle Scholar
• Birman-Deych E, Radford MJ, Nilasena DS, Gage BF. Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation. Stroke37, 1070–1074 (2006).
   PubMed Web of Science ®Google Scholar
• Friberg L, Hammar N, Ringh M, Pettersson H, Rosenqvist M. Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study). Eur. Heart J.27, 1954–1964 (2006).
   PubMed Web of Science ®Google Scholar
• Inoue H, Nozawa T, Okumura K et al. Attitudes of Japanese cardiologists toward anticoagulation for nonvalvular atrial fibrillation and reasons for its underuse. Circ. J.68, 417–421 (2004).
   PubMedGoogle Scholar
• Murphy NF, Simpson CR, Jhund PS et al. A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland. Heart93, 606–612 (2007).
   PubMed Web of Science ®Google Scholar
• Tapson VF, Hyers TM, Waldo AL et al. Antithrombotic therapy practices in US hospitals in an era of practice guidelines. Arch. Intern. Med.165, 1458–1464 (2005).
   PubMed Web of Science ®Google Scholar
• Gurwitz JH, Field TS, Radford MJ et al. The safety of warfarin therapy in the nursing home setting. Am. J. Med.120, 539–544 (2007).
   PubMed Web of Science ®Google Scholar
• McBride D, Bruggenjurgen B, Roll S, Willich SN. Anticoagulation treatment for the reduction of stroke in atrial fibrillation: a cohort study to examine the gap between guidelines and routine medical practice. J. Thromb. Thrombolysis24, 65–72 (2007).
   PubMed Web of Science ®Google Scholar
• Heit JA, O’Fallon WM, Petterson TM et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch. Intern. Med.162, 1245–1248 (2002).
   PubMed Web of Science ®Google Scholar
• Lee AY, Hirsh J. Diagnosis and treatment of venous thromboembolism. Annu. Rev. Med.53, 15–33 (2002).
   PubMedGoogle Scholar
• White RH. The epidemiology of venous thromboembolism. Circulation107, I4–I8 (2003).
   PubMed Web of Science ®Google Scholar
• Warwick D, Friedman RJ, Agnelli G et al. Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry. J. Bone Joint Surg. Br.89, 799–807 (2007).
   PubMed Web of Science ®Google Scholar
• Ansell J, Hirsh J, Dalen J et al. Managing oral anticoagulant therapy. Chest119, 22S–38S (2001).
   PubMed Web of Science ®Google Scholar
• Hirsh J, Dalen J, Anderson DR et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest119, 8S–21S (2001).
   PubMed Web of Science ®Google Scholar
• Meurer LN, Jamieson B, Guthmann R. Clinical inquiries. What is the interval for monitoring warfarin therapy once therapeutic levels have been achieved? J. Fam. Pract.54, 171–172 (2005).
   PubMedGoogle Scholar
• Hixson-Wallace JA, Dotson JB, Blakey SA. Effect of regimen complexity on patient satisfaction and compliance with warfarin therapy. Clin. Appl. Thromb. Hemost.7, 33–37 (2001).
   PubMed Web of Science ®Google Scholar
• Shikiar R, Rentz AM. Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value Health7, 204–215 (2004).
   PubMed Web of Science ®Google Scholar
• Sawicki PT. A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. JAMA281, 145–150 (1999).
   PubMed Web of Science ®Google Scholar
• Cromheecke ME, Levi M, Colly LP et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet356, 97–102 (2000).
   PubMed Web of Science ®Google Scholar
• Samsa G, Matchar DB, Dolor RJ et al. A new instrument for measuring anticoagulation-related quality of life: development and preliminary validation. Health Qual. Life Outcomes2, 22 (2004).
   PubMedGoogle Scholar
• Hedner E, Carlsson J, Kulich KR et al. An instrument for measuring health-related quality of life in patients with Deep Venous Thrombosis (DVT): development and validation of Deep Venous Thrombosis Quality of Life (DVTQoL) questionnaire. Health Qual. Life Outcomes2, 30 (2004).
   PubMedGoogle Scholar
• Prieto L, Alonso J, Lamarca R. Classical test theory versus Rasch analysis for quality of life questionnaire reduction. Health Qual. Life Outcomes1, 27 (2003).
   PubMedGoogle Scholar
• Harrison L, McGinnis J, Crowther M, Ginsberg J, Hirsh J. Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin. Arch. Intern. Med.158, 2001–2003 (1998).
   PubMedGoogle Scholar
• Lancaster TR, Singer DE, Sheehan MA et al. The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. Arch. Intern. Med.151, 1944–1949 (1991).
   PubMed Web of Science ®Google Scholar
• Arnsten JH, Gelfand JM, Singer DE. Determinants of compliance with anticoagulation: a case-control study. Am. J. Med.103, 11–17 (1997).
   PubMed Web of Science ®Google Scholar
• Khan TI, Kamali F, Kesteven P, Avery P, Wynne H. The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. Br. J. Haematol.126, 557–564 (2004).
   PubMed Web of Science ®Google Scholar
• Barcellona D, Contu P, Sorano GG, Pengo V, Marongiu F. The management of oral anticoagulant therapy: the patient’s point of view. Thromb. Haemost.83, 49–53 (2000).
   PubMed Web of Science ®Google Scholar
• Davis NJ, Billet HH, Cohen HW, Arnsten JH. Impact of adherence, knowledge, and quality of life on anticoagulation control. Ann. Pharmacother.39, 632–636 (2005).
   PubMed Web of Science ®Google Scholar
• Kulinna W, Ney D, Wenzel T, Heene DL, Harenberg J. The effect of self-monitoring the INR on quality of anticoagulation and quality of life. Semin. Thromb. Hemost.25, 123–126 (1999).
   PubMed Web of Science ®Google Scholar
• Willke RJ, Burke LB, Erickson P. Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels. Control. Clin. Trials25, 535–552 (2004).
   PubMedGoogle Scholar
• Anderson RT, Skovlund SE, Marrero D et al. Development and validation of the insulin treatment satisfaction questionnaire. Clin. Ther.26, 565–578 (2004).
   PubMed Web of Science ®Google Scholar
• Lewis KS, Bradley C, Knight G, Boulton AJ, Ward JD. A measure of treatment satisfaction designed specifically for people with insulin-dependent diabetes. Diabet. Med.5, 235–242 (1988).
   PubMed Web of Science ®Google Scholar
• Bradley C. Diabetes treatment satisfaction questionnaire. Change version for use alongside status version provides appropriate solution where ceiling effects occur. Diabetes Care22, 530–532 (1999).
   PubMed Web of Science ®Google Scholar
• Atkinson MJ, Kumar R, Cappelleri JC, Hass SL. Hierarchical construct validity of the Treatment Satisfaction Questionnaire for Medication (TSQM version II) among outpatient pharmacy consumers. Value Health8, S9–S24 (2005).
   PubMed Web of Science ®Google Scholar
• Monane M, Bohn RL, Gurwitz JH et al. Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. Am. J. Public Health86, 1805–1808 (1996).
   PubMed Web of Science ®Google Scholar
• Williams ML, Morris MT, Ahmad U et al. Racial differences in compliance with NCEP-II recommendations for secondary prevention at a Veterans Affairs medical center. Ethn. Dis.12, S1–S62 (2002).
   Google Scholar